A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Empagliflozin Impurity 109 - Request Quote

Picture of Empagliflozin Impurity 109

Empagliflozin Impurity 109

SZ CAT No:SZ-E009166
CAS No
NA
Mol.F.
C30H26Br2Cl2O2
Mol.Wt.
649.2
Inv. Status
Synthesis on demand

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Empagliflozin Impurity 109 is chemically 4-Bromo-2-(2-(4-(4-(5-bromo-2-chlorobenzyl)phenoxy)butoxy)benzyl)-1-chlorobenzene. Empagliflozin Impurity 109 is supplied with detailed characterization data compliant with regulatory guideline. Empagliflozin Impurity 109 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Empagliflozin.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

buy high quality Empagliflozin Impurity 109

Purchase Empagliflozin Impurity 109

Empagliflozin Impurity 109 suppliers

Empagliflozin Impurity 109 manufacturers

Empagliflozin Impurity 109 price

Order Empagliflozin Impurity 109

Enquire Empagliflozin Impurity 109

Empagliflozin Impurity 109 cost

Empagliflozin Impurity 109 Supplier

Empagliflozin Impurity 109 Distributor

Empagliflozin Impurity 109 for Method Validation

Empagliflozin Reference Standard

Empagliflozin Impurity 109 for ANDA Filing

Empagliflozin Impurity 109 for Forced Degradation Studies

Empagliflozin Impurity 109 Identification Standards

Empagliflozin Impurity 109 for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,